Abstract
GABAA receptors on thalamic relay and reticular (nRT) neurons play a critical role in thalamocortical mechanisms underlying absence seizures. Studies with absence seizure-prone rats and transgenic mice have taken advantage of differences in the subunit compositions of GABAA receptors in the two thalamic cell populations to clarify thalamocortical rhythm generating mechanisms and explain the antiabsence activity of benzodiazepines. The relevance of this work is highlighted by the recent finding of a mutation in the GABAA receptor γ2 subunit in a family with childhood absence seizures.
Introduction
The potential combinations of at least 23 subunit forms create a bewildering array of potential subunit combinations; however, in the endoplasmic reticulum and golgi apparatus, a restricted number of subunit combinations assemble together and are properly packaged, processed, and trafficked to the cell surface (5). In mammalian CNS, the GABAA R is believed to be composed of α, β, or β and θ, plus one or more of the γ, δ, ∊ subunits (3,4). The α1β2β2 combination accounts for approximately 43% of GABAAR (6), although individual subunits display distinct regional neuronal and subcellular localization characteristics (7–9).
GABAAR Subtypes in Thalamocortical Circuitry
The GABAAR is of prime importance in the pathogenesis of absence epilepsy because of its apparent role in the synchronization and desynchronization of thalamocortical circuitry. Perturbation of this process leads to the generation of absence seizures. The oscillatory burst firing of thalamocortical circuitry is attributed to the ability of neurons located in the nucleus reticularis thalami (nRT) to impose their own oscillatory behavior on thalamocortical relay neurons located in the ventral basalis (VB) of the thalamus. The ability of the nRT to switch between oscillatory and burst firing dictates electroencephelographic (EEG) synchronization and desynchronization. The nRT consists of GABAergic neurons that project to the VB, providing inhibitory input. Also, GABAergic nRT neurons project onto one another providing intra-nRT inhibition, which decreases input to the VB. The nRT GABAergic neurons receive glutamatergic inputs from thalamocortical VB fibers and also from corticothalamic fibers projecting back from layer VI of the cerebral cortex (10–17). Within this circuitry, GABAAR are located on glutamatergic thalamocortical and corticothalamic neurons as well as GABAergic nRT neurons.
The localization of GABAAR subunit proteins have revealed a complementary distribution within thalamocortical circuitry. The nRT is rich in α1 α3, β1, β3, and γ2 subunits and is virtually devoid of β2 and δ subunits. In contrast, the thalamic relay neurons have high levels of α1, α4, β2, δ subunits but show no detectable levels of the β3 subunit(7). Electrophysiological studies have indicated that inhibitory postsynaptic currents differ in the nRT and thalamic relay neurons (18) a functional difference likely due to the distinct population of GABAAR subunits in each region.
The action of benzodiazepines within thalamocortical circuitry illustrates further the functional differences between GABAAR localized to the nRT versus those found on thalamic relay neurons. Systematic stimulation of GABAAR within thalamocortical circuitry via administration of GABAAR agonists, GABA transaminase inhibitors, or GABA reuptake inhibitors causes an exacerbation of the duration of spike-and-wave discharge (SWD) in pharmacological and genetic animal models of absence seizures (19–23). Because benzodiazepines augment GABAAR-mediated neurotransmission, these compounds would be predicted to exacerbate absence seizures in a similar fashion; however, this class of drugs has been shown to have both experimental and clinical therapeutic efficacy in the treatment of absence seizures. The reason for this dichotomy is that benzodiazepines enhance GABAAR-mediated inhibition within the nRT, resulting in a decreased inhibition by the nRT of thalamic relay neurons (24). This specificity of action of benzodiazepines on nRT GABAAR may be explained by the tissue-specific subunit composition of GABAAR within the nRT versus those within thalamic relay nuclei. A large number of thalamic relay nuclei contain GABAAR comprised of the δ subunit; however, GABAARs containing the δ subunit are known to be benzodiazepine insensitive. Furthermore, many GABAAR in thalamic nuclei contain the benzodiazepine-in-sensitive α4 subunit. Conversely, in the nRT, a large number of GABAAR contain a benzodiazepine-sensitive γ2 subunit in place of the δ subunit, as well as the benzodiazepine-sensitive α3 subunit(7).
Thalamocortical GABAAR and Absence Seizures
Microinjection studies in the genetic absence epilepsy rats from Strasbourg (GAERS) have helped to define the role of GABAAR in the thalamocortical circuitry in the pathogenesis of absence seizures in this genetic model. Application of γ-vinyl GABA (GVG), an irreversible GABA transaminase inhibitor, into the nRT increases intra-nRT inhibition and results in less inhibitory input onto thalamic relay neurons. The net result is an inhibition of SWD and attenuation of absence seizures. Conversely, the administration of GVG into thalamic relay nuclei activates GABAAR on the thalamic relay neurons, resulting in increased inhibitory input and exacerbation of the absence seizures (25).
While GABAAR agonists exacerbate absence seizures, GABAAR antagonists, such as pentylenetetrazole, bicuculline, and picrotoxin, fail to block experimental absence seizures (21). Administration of GABAAR antagonists induce a dose-dependent continuum of seizure types. Low doses induce absence-like seizures; intermediate doses produce clonic seizures responsive to antiabsence drugs, and high doses induce tonic seizures unresponsive to antiabsence drugs (26–29). Administration of low dose GABAAR antagonists directly into the nRT results in the enhanced oscillatory synchrony observed in absence seizures, whereas application of GABAAR antagonists to the relay neurons had no effect (30). However, recently Staak and Pape reported that microinjection of bicuculline into the thalamic relay neurons exacerbated SWD in the WAG/Rij rat model of absence epilepsy (31).
The data suggest that low dose GABAAR antagonist-induced absence seizures result from the involvement of GABAAR within the nRT which mediate a decrease in intra-nRT inhibition. Mutagenesis studies have revealed that two key residues in the second transmembrane domain of the β3 subunit are essential for high-affinity antagonist binding of tert-butylbicyclophosphorothionate and picrotoxin (32,33). The fact that this high-affinity antagonist binding β3 subunit is present in the nRT and not on the thalamic relay neurons may explain the nRT-specific effect of low-dose GABAAR antagonists in their ability to precipitate absence seizures.
Recently, a mutation in the γ2 subunit has been linked to childhood absence of epilepsy and febrile seizures (34). In vitro replication of this mutation in recombinant receptors revealed an abolished sensitivity to diazepam. The γ2 mutation would be predicted to render GABAAR in the nRT benzodiazepine-insensitive and thus would be unable to augment intra-nRT inhibition. This study strengthens the concept that physiologically relevant endogenous benzodiazepines exist and play an important role in the prevention of absence seizures in humans.
GABAAR Mutant Mice
Subunit-Specific Knockouts
Valuable insights regarding GABAAR-mediated inhibition, subunit assembly, and receptor trafficking have been gained from studies in which the gene for a single subunit has been disrupted, and effectively deleted (35). Currently, knockout mice have been reported for α1, α6, β2, β3, δ, and γ2 subunits. Decreased surface expression of the δ subunit in α6 knockouts concurs with in vitro data indicating preferential assembly of these two subunits (36). In addition, the decreased surface expression of all six α subunits in the β2 knockout mice suggests that the β2 subunit assembles with all six subunits (37).
The major limitations inherent in the gene disruption technique that constrain our ability to interpret phenotypes resulting from knockout techniques are those developmental mechanisms that emerge to compensate for the absence of the gene of interest. For example, although the δ knockout mice displays attenuated sensitivity to the modulatory effects of neurosteroid, there is an associated upregulation of those GABAAR containing the γ2 subunit (38). Similarly, α6 knockout mice have increased sensitivity to diazepam-induced motor impairment, but there is an associated increase in β3-containing GABAAR, as well as an upregulation of a K+ channel (TASK-1) in granule cells.
Near-lethal gene disruptions also present interpretive problems. The β3 and γ2 knockout mice exhibit extremely high mortality rates, with only a minor percentage of pups surviving. Several of the knockout mice contain a neomycin-resistance cassette used in the gene disruption procedure. This cassette has been shown to impart inhibitory influences on neighboring genes in several nonneuronal systems (39–41). This scenario is likely to explain the widespread decrease of α1 and β2 expression observed in the α6-/- mice because the three subunit genes are located next to each other, in a gene cluster (42). This problem can be avoided in future mutants by strategic removal of the neomycin resistance gene following the creation of the mutant mice, as has been done in the α1-/- and β2-/- mice (12).
Subtype Specific Benzodiazepine Binding and Knock-In Point Mutation Mice
Benzodiazepines bind to the modulatory site on the GABAAR in a high-affinity (nM) and low-affinity (uM) manner (43). The GABAAR with the classic high-affinity benzodiazepine binding site contains an α, β, γ subunit combination. Recombinant receptor studies have indicated that the binding site is located between the interface of the α and γ subunits and that the α subunit is restricted to α1, α2, α3, and α5 (44). No benzodiazepine binding is detectable in γ2-/- mice (45).
Recently, single amino acid substitutions in GABAAR subunits have been incorporated into germlines of mice. This method alters one pharmacological aspect of a subunit while closely preserving the native GABAAR composition, hence preventing developmental and compensatory in vivo responses to a missing subunit. The benzodiazepine-sensitive α1, α2, α3, and α5 subunits have a conserved histidine amino acid residue in the binding domain, whereas benzodiazepine-insensitive α4 and α6 subunits have an arginine at the equivalent residue. Point mutations converting the histidine to arginine rendered benzodiazepine-sensitive α subunits to be insensitive in vitro. When this point mutation was made in the α1 subunit of a mutant mouse line, benzodiazepines failed to induce sedation and anterograde amnesia and had a reduced anticonvulsant potency (46,47). However, neither diazepam-induced inhibition of REM sleep nor the effect of diazepam on EEG during sleep and wakefulness were altered in the a1 mutants (48). Similar mutations in the α2 and α3 subunits revealed that α2- and not α3-containing receptors mediated the anxiolytic response to benzodiazepines (49).
Relevance of GABAA Mutant Mice to Absence Seizures
Studies of β3-/- mice have provided valuable insight into the role of this subunit in thalamocortical circuitry. GABAAR-mediated inhibition was essentially abolished within the nRT, but was unaffected in the thalamic relay neurons. This observation is in agreement with the restricted expression of β3 containing GABAAR, in thalamic relay nuclei where the neurons contain primarily the β2 subunit. In addition, oscillatory synchrony was greatly intensified in the β3-/- mice. These observations strongly suggest that recurrent inhibitory connections within the nRT act as desynchronizers in thalamocortical circuitry and that β3 containing GABAAR are primarily responsible for GABAAR-mediated intra-nRT inhibition in vivo (30).
The β2-/- mice are an intriguing mutant because loss of the major β subunit in the CNS results in an ∼ 60% loss of GABAAR throughout the brain; however, neither an overt phenotype nor spontaneous seizures are apparent (37). This lack of a demonstrable phenotype may be explained partially by the existence and potential functional overlap of β2 with other β subunits in many neurons. In thalamocortical circuitry, the relay neurons of the β2-/- mice appear to contain only low levels of the β1 subunit.
Similarly, δ-/- mice are of particular interest because of the restricted expression of δ containing GABAAR in the thalamic relay neurons of the VB versus nRT neurons. These mutant mice are reported to have attenuated responses to neuroactive steroids (38). There are few published data available regarding the effects of chemically induced absence seizures in δ-/- mice. Neuroactive steroids have been shown to potentiate low-dose pentylenetetrazole-induced absence in δ+/+ but not δ-/- mice; however, absence seizure activity was measured in these studies by observation of hypoactivity rather than by the more precise method of EEG quantitation.
Footnotes
Acknowledgments
This work was supported in part by the Canadian Institutes of Health Research and the Bloorview Childrens Hospital Foundation.
